Latest Headlines

  1. Bora Pharmaceuticals Wins World Finance Sustainability Award 2025 6/23/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, today announced that it has been named a winner of the World Finance Sustainability Awards 2025, in recognition of its industry-leading efforts to embed sustainability into the heart of its operations.

  2. CRDMO Aragen Completes Facility And Equipment Qualification; First GMP batches In Late July 2025 6/20/2025

    Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025. Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.

  3. Bionova Scientific Expands Capacity And Enters Advanced Therapies Market 6/18/2025

    Bionova Scientific, a contract development and manufacturing organization (CDMO), is entering the advanced therapy manufacturing space.

  4. LOTTE BIOLOGICS Signs Antibody Manufacturing Contract With Ottimo Pharma 6/18/2025

    LOTTE BIOLOGICS announced on June 19, 2025 that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, one-of-a-kind PD1/VEGFR2 dual pathway antibodies to extend the lives of people living with cancer.

  5. Leading European Biologics CDMO Mabion, Releases First Batch Of Novalgen's Next-Generation T-Cell Engager, NVG-222 For First In-Human Clinical Trials 6/17/2025

    In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end-to-end biologics CDMO Mabion have entered into a strategic development and manufacturing partnership with London based NovalGen an existing client with whom cooperation under CDMO orders was first disclosed in current report No. 13/2024 dated August 16, 2024.

  6. Mabion Launches €500,000 Services Contest To Support Next-Gen Oncology Breakthroughs 6/17/2025

    Mabion, a leading biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of, recombinant protein-based cancer therapies.

  7. Ecolab Life Sciences Launches New Bioprocessing Purification Resin To Drive Manufacturing Productivity 6/16/2025

    Ecolab Life Sciences today announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process.

  8. Nanoform Starts Pivotal Human Bioequivalence Studies Of Nanoenzalutamide 6/12/2025

    Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had started pivotal relative bioequivalence studies of Nanoenzalutamide, the nanocrystalline-enabled enzalutamide tablet formulation, a potential alternative to the amorphous solid dispersion (ASD) used in XTANDI® (enzalutamide) [1], the number one prescribed androgen receptor inhibitor [2] approved to treat prostate cancer.

  9. Parker To help Biopharmaceutical Manufacturers Transform Tangential Flow Filtration 6/12/2025

    Optimizing, streamlining and scaling tangential flow filtration processing in the biopharmaceutical industry will be the focus of a Parker webinar this month.

  10. Simtra BioPharma Solutions And MilliporeSigma Announce Strategic Alliance For Antibody Drug Conjugates Drug Substance And Drug Product Manufacturing Services 6/12/2025